首页> 外文OA文献 >Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

【2h】

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

机译：pfs25-Epa /alhydrogel®的安全性和免疫原性，一种针对恶性疟原虫的传播阻断疫苗：疟疾天真成人的开放标签研究。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kawsar R Talaat; Ruth D Ellis; Janet Hurd; Autumn Hentrich; Erin Gabriel; Noreen A Hynes; Kelly M Rausch; Daming Zhu; Olga Muratova; Raul Herrera; Charles Anderson; David Jones; Joan Aebig; Sarah Brockley; Nicholas J MacDonald; Xiaowei Wang; Michael P Fay; Sara A Healy; Anna P Durbin; David L Narum; Yimin Wu; Patrick E Duffy;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum : a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults [J] . Issaka Sagara, Sara A Healy, Mahamadoun H Assadou, The Lancet infectious diseases . 2018,第9期

机译：PFS25H-EPA / Alhydrogel的安全性和免疫原性，对疟原虫的传动阻断疫苗：健康玛丽安成年人的随机，双盲，比较，对照，剂量升级研究
2. A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel (R) + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults [J] . Sagara Issaka, Ellis Ruth D., Dicko Alassane, Vaccine . 2009,第52期

机译：AMA1-C1 / Alhydrogel（R）+ CPG 7909疫苗在半免疫马里成人恶性疟原虫疟疾中的安全性和免疫原性的随机对照1期研究
3. Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults. [J] . Pierce M. A., Ellis R. D., Martin L. B., Vaccine . 2010,第10期

机译：澳大利亚成人恶性疟原虫血液阶段疟疾疫苗AMA1-C1 / ISA 720的1期安全性和免疫原性试验。
4. Immunogenicity of Malaria Vaccine Candidate-Plasmodium falciparum Merozoite Surface Protein 5 (PfMSP5) Expressed in Bacillus subtilis [C] . Chittibabu Gottimukkala, Charles Ma, Hans J. Netter International Conference on Chemical, Biological and Environmental Engineering . 2014

机译：疟疾疫苗候选疟原虫的免疫原性是恶魔植物在枯草芽孢杆菌中表达的疟原虫候选疟原虫疟原虫表面蛋白5（PFMSP5）
5. Evaluation of Plasmodium falciparum transmission blocking immunity induced by candidate vaccine antigens Pfs25 and Pfs48/45 and naturally induced immune responses in Zambian children. [D] . LeBlanc, Ralph E. 2009

机译：评价候选疫苗抗原Pfs25和Pfs48 / 45诱导的恶性疟原虫传播阻断免疫以及赞比亚儿童的自然诱导的免疫反应。
6. Safety and Immunogenicity of Pfs25-EPA/Alhydrogel® a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults [O] . Kawsar R. Talaat, Ruth D. Ellis, Janet Hurd, -1

机译：Pfs25-EPA /Alhydrogel®一种抗恶性疟原虫的传播阻断疫苗的安全性和免疫原性：一项针对未患疟疾的成年人的开放标签研究
7. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults [O] . Issaka Sagara, Sara A Healy, Mahamadoun H Assadou, 2018

机译：PFS25H-EPA / Alhydrogel的安全性和免疫原性，抗疟原虫的传动阻断疫苗：健康玛丽安成年人的随机，双盲，比较，控制，剂量升级研究
8. Impact of Transmission Intensity and Age on Plasmodium Falciparum Density andAssociated Fever: Implications for Malaria Vaccine Trial Design [R] . Beadle, C., McElroy, P. D., Oster, C. N., 1995

机译：传播强度和年龄对恶性疟原虫密度和相关发热的影响：对疟疾疫苗试验设计的影响

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

著录项

引文网络

相似文献

相关主题

期刊订阅